Seaport Res Ptn Analysts Cut Earnings Estimates for Innospec

Innospec Inc. (NASDAQ:IOSP) – Analysts at Seaport Res Ptn decreased their Q2 2025 earnings per share estimates for shares of Innospec in a research report issued on Monday, February 24th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will earn $1.35 per share for the quarter, down from their prior forecast of $1.39. The consensus estimate for Innospec’s current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec’s Q3 2025 earnings at $1.39 EPS, Q4 2025 earnings at $1.60 EPS, FY2025 earnings at $5.72 EPS, Q1 2026 earnings at $1.63 EPS, Q2 2026 earnings at $1.57 EPS, Q3 2026 earnings at $1.59 EPS, Q4 2026 earnings at $1.79 EPS and FY2026 earnings at $6.58 EPS.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.05. Innospec had a return on equity of 12.27% and a net margin of 1.93%. The company had revenue of $466.80 million for the quarter, compared to analyst estimates of $447.43 million.

Separately, StockNews.com downgraded shares of Innospec from a “strong-buy” rating to a “buy” rating in a research note on Saturday, January 11th.

Innospec Stock Up 2.3 %

Shares of NASDAQ IOSP opened at $104.38 on Wednesday. Innospec has a 12-month low of $99.49 and a 12-month high of $133.71. The firm’s 50-day simple moving average is $110.41 and its 200 day simple moving average is $112.37. The company has a market cap of $2.61 billion, a price-to-earnings ratio of 73.51 and a beta of 1.09.

Insider Buying and Selling

In other news, VP Philip John Boon sold 3,754 shares of Innospec stock in a transaction on Friday, February 21st. The stock was sold at an average price of $103.30, for a total value of $387,788.20. Following the completion of the sale, the vice president now directly owns 20,079 shares of the company’s stock, valued at approximately $2,074,160.70. This trade represents a 15.75 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Milton C. Blackmore sold 652 shares of the company’s stock in a transaction on Friday, February 21st. The shares were sold at an average price of $103.30, for a total value of $67,351.60. Following the transaction, the director now directly owns 8,376 shares in the company, valued at $865,240.80. This trade represents a 7.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 7,098 shares of company stock worth $733,223 in the last quarter. Insiders own 1.52% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Blue Trust Inc. lifted its holdings in Innospec by 503.9% in the third quarter. Blue Trust Inc. now owns 779 shares of the specialty chemicals company’s stock valued at $96,000 after buying an additional 650 shares during the period. Raymond James & Associates lifted its stake in shares of Innospec by 10.0% in the 3rd quarter. Raymond James & Associates now owns 83,843 shares of the specialty chemicals company’s stock valued at $9,482,000 after purchasing an additional 7,616 shares during the period. New York State Teachers Retirement System boosted its position in shares of Innospec by 2.6% in the 3rd quarter. New York State Teachers Retirement System now owns 14,781 shares of the specialty chemicals company’s stock worth $1,672,000 after purchasing an additional 371 shares during the last quarter. US Bancorp DE grew its stake in shares of Innospec by 323.6% during the third quarter. US Bancorp DE now owns 5,490 shares of the specialty chemicals company’s stock worth $621,000 after purchasing an additional 4,194 shares during the period. Finally, Leeward Investments LLC MA grew its stake in shares of Innospec by 22.4% during the third quarter. Leeward Investments LLC MA now owns 86,004 shares of the specialty chemicals company’s stock worth $9,726,000 after purchasing an additional 15,750 shares during the period. Institutional investors own 96.64% of the company’s stock.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.